Molbio Diagnostics, a pioneer in global healthcare based in Goa, has announced the appointment of two new Independent Directors to its board, Professor (Dr) Balram Bhargava and Dr Arun Kumar Jha.

These appointments come as the company continues to strengthen its Leadership and make significant strides in healthcare accessibility with its innovative solutions that cater to the remotest regions globally.

Professor (Dr) Balram Bhargava is a leader in the public health sector with over 35 years of experience in medical research and health system strengthening. His previous roles include Director-General of the Indian Council of Medical Research and Secretary of India’s Department of Health Research, being at the forefront of managing several public health crises in India.

Dr Bhargava’s ongoing work in pandemic preparedness and health policy has been instrumental in promoting affordable healthcare innovations. His leadership at the National Academy of Sciences and numerous other institutions showcases his commitment to enhancing health outcomes worldwide.

Dr Arun Kumar Jha brings a wealth of experience in public health and policy, including his role as an Adviser in the Department of Economic Affairs, Ministry of Finance, and as an Economic Adviser in the Department of Health & Family Welfare, Ministry of Health & Family Welfare. He is currently working as the Chancellor of the National Institute of Advanced Manufacturing Technology (NIAMT) and Senior Adviser in John Snow India. With his active involvement with the Government of India in schemes and programs that focus on tuberculosis elimination in the country, Dr Jha has recently signed up an assignment with the Stop TB Partnership and United Nations Office for Project Services (UNOPS), positioning him as an invaluable asset in advancing Molbio’s mission to support global health initiatives.